Show metadata Hide metadata

(19)

(11)

2 736 217

(13)

(51)

IPC

C07D487/04(2006-01-01)

C07D519/00(2006-01-01)

A61K31/407(2006-01-01)

A61P7/00(2006-01-01)

(21) (22)

Application

2019137023, 2018-03-20

(24)

Start date

2018-03-20

(22)

Actual filing date

2018-03-20

(45)

Published

2020-11-12

(72)

Inventor

Eriksson, AnnaGrin, NilGustafson, GariKhan, BinsunLanchia, Ml. Devid R.Mitchell, LornaRichard, DevidShelekhin, TatyanaSmit, Chejz K.Van, ChzhungoChzhen, Syaochzhan

(73)

Holder

Forma Therapeutics, Inc.

PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) Russian patent published in 2020 - IPC C07D487/04 C07D519/00 A61K31/407 A61P7/00

Abstract RU 2736217 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention relates to a pharmaceutical composition having pyruvate kinase (PKR) activator activity containing an effective amount of a compound of formula I, where values of R¹-R¹¹, R^1'-R^11', Y are specified in the claim.

EFFECT: pharmaceutical composition is intended for treating diseases and disorders associated with PKR and/or PKM2, such as pyruvate kinase (PKD) insufficiency, sickle cell disease (SCD) and thalassemia.

24 cl, 1 dwg, 7 tbl, 46 ex

Similar patents RU2736217C2

Title	Year	Author	Number
8-CARBAMOYL-2-(2,3-DI-SUBSTITUTED PYRID-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS APOPTOSIS-INDUCING AGENTS FOR CANCER TREATMENT	2012	Vang Li Douerti Dzhordzh Van Silu Tao Chzhi-Fu Branko Milan Kanzer Aaron R. Uendt Majkl D. Sun Syaokhun Frej Robin Khansen Todd M. Sallivan Dzherard M. Dzhadd Endryu Sauers Endryu	RU2625315C2
BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS	2018	Blank, Brian R. Pitzen, Jennifer Wang, Gang Won, Walter S. Tzitzilonis, Christos Li, Jie Jack Koltun, Elena S. Aay, Naing Buckl, Andreas Mellem, Kevin Semko, Christopher Jogalekar, Ash Kiss, Gert Gill, Adrian	RU2776846C2
APOPTOSIS-INDUCING AGENTS	2018	Liu, Hongbin Rong, Yue Zhang, Huajie Chen, Zhifang Tan, Rui He, Chengxi Li, Zhifu Zhou, Zuwen Tan, Haohan Ran, Kai Wang, Xianlong Zou, Zongyao Jiang, Lihua Liu, Yanxin Zhao, Xingdong Wang, Weibo Fu, Jiemin	RU2782469C2
METHOD FOR INHIBITION OF RAF KINASE-MEDIATED GROWTH OF TUMOR CELLS, HETEROCYCLIC UREA DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS)	1998	Vud Dzhil Eh. Dzhonson Dzhefri Djuma Zhak Kajre Judehj Li Uehndi Louinger Timoti Bruno Paul'Sen Khol'Ger Redmehn Aniko Renik Dzhouehl Ridl' Bernd Sibli Robert Skott Uil'Jam Dzh. Smit Rodzher Eh. Khatoum-Mokdad Kholija	RU2232015C2
MEK INHIBITORS AND THEIR THERAPEUTIC USE	2021	Kholl, Brett Mettyu Dekorte, Bart Liven King, Piter Dzhon Linders, Ruben Vegert, Anita Fouler, Kevin Kolitts, Sara Dudman, Robin Polakker, Yarno Folmer, Rutger Khenk Adrian	RU2812929C1
COMPOSITIONS BASED ON SHP2 INHIBITOR AND METHODS OF CANCER TREATMENT	2018	Nichols, Robert J. Goldsmith, Mark A. Schulze, Christopher Smith, Jacqueline Wildes, David E. Kelsey, Stephen Singh, Mallika	RU2805355C2
AGENTS CAUSING APOPTOSIS AND INTENDED FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES	2012	Van Le Douerti Dzhordzh Van Silu Tao Chzhi-Fu Branko Milan Kanzer Aaron R. Uendt Majkl D. Sun Syaokhun Frej Robin Khansen Todd M. Sallivan Dzherard M. Dzhadd Endryu Sauers Endryu	RU2594282C2
NEW BICYCLIC COMPOUNDS AS DUAL INHIBITORS OF ATX/CA	2016	Di Dzhordzho Patrik Khert Zherom Khuntsiker Daniel Mattej Patritsio Rudolf Markus Shmits Petra Ullmer Kristof	RU2724899C2
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS	2006	Chafeev Mikhail Chovdkhuri Sultan Frejzer Robert Fu Tszjan'Min' Kambodzh Radzhender Sviridov Sergej Bagkherzadekh Mekhran Seid Lju Shifehn Sun' Tszjaniu	RU2428424C2
METHOD OF PRODUCING ISOTHIAZOLE DERIVATIVES	2005	Dejmon Dehvid B. Dzhouns Brajan P.	RU2349588C2

RU 2 736 217 C2

Authors

Eriksson, Anna

Grin, Nil

Gustafson, Gari

Khan, Binsun

Lanchia, Ml. Devid R.

Mitchell, Lorna

Richard, Devid

Shelekhin, Tatyana

Smit, Chejz K.

Van, Chzhungo

Chzhen, Syaochzhan

Dates

2020-11-12—Published

2018-03-20—Filed